Wu, Xingwei
Fu, Minjie
Ge, Chang
Zhou, Hanyu
Huang, Haoyu
Zhong, Min
Zhang, Mengying
Xu, Hao
Zhu, Guoping
Hua, Wei
Lv, Kun
Yang, Hui https://orcid.org/0000-0002-5307-3970
Funding for this research was provided by:
National Nature Science Foundation of China (81802503, 81772180, 82072370)
Article History
Received: 3 August 2023
Accepted: 28 December 2023
First Online: 9 January 2024
Declarations
:
: The protocols used in this study were approved by the Ethical Review Committees of Fudan university shanghai cancer center and Yijishan hospital of Wannan medical college, and written informed consent was provided from all the patients. The experimental research on xenografted tumor model has been approved by the Ethic Committee for Clinical Research of the First Affiliated Hospital of Wannan Medical College (IRB file No. LLSC-2020–095) and reporting of these experiments complied with the ARRIVE (Animal Research: Reporting of In Vivo Experiments) guidelines. These studies were conducted in accordance with the Declaration of Helsinki. All animal experiments were strictly implemented in compliance with the NIH Guide for the Care and Use of Laboratory Animals.
: Not applicable.
: Not applicable.
: The authors declare no competing interests.